Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Medtronic announces $550M acquisition | Faster IVL catheter impresses | Who do Americans trust? | Burnout among surgeons

News You Need to Know Today
Medtronic announces $550M acquisition | Faster IVL catheter impresses | Who do Americans trust? | Burnout among surgeons
Wednesday, March 11, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Medtronic to acquire medtech company Scientia Vascular for $550M

Scientia Vascular, a Salt Lake City-based medtech company focused on developing new vascular devices, was founded in 2007 and has more than 300 employees.

READ MORE >
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic to acquire medtech company Scientia Vascular for $550M

Share on Twitter Share on Facebook Share on Linkedin
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
Scientia Vascular, a Salt Lake City-based medtech company focused on developing new vascular devices, was founded in 2007 and has more than 300 employees.
READ MORE >

Shockwave Medical’s new coronary IVL catheter, now twice as fast, impresses after 30 days

The new-look device was designed to deliver 10 pulses to severely calcified coronary lesions in five seconds. Early data linked the catheter with positive 30-day safety and effectiveness outcomes.

READ MORE >
Shockwave Medical IVL
Share on Twitter Share on Facebook Share on Linkedin

Shockwave Medical’s new coronary IVL catheter, now twice as fast, impresses after 30 days

Share on Twitter Share on Facebook Share on Linkedin
Shockwave Medical IVL
The new-look device was designed to deliver 10 pulses to severely calcified coronary lesions in five seconds. Early data linked the catheter with positive 30-day safety and effectiveness outcomes.
READ MORE >

Public trust in US health agencies falls under Trump—confidence in AHA still quite high

The public has more confidence in the American Heart Association than it does in the FDA, CMS or any other federal health agencies. 

READ MORE >
Trump White House RFK Make America Health Again
Share on Twitter Share on Facebook Share on Linkedin

Public trust in US health agencies falls under Trump—confidence in AHA still quite high

Share on Twitter Share on Facebook Share on Linkedin
Trump White House RFK Make America Health Again
The public has more confidence in the American Heart Association than it does in the FDA, CMS or any other federal health agencies. 
READ MORE >

Nearly half of all surgeons have considered leaving the profession due to burnout

Burnout remains one of the biggest issues in modern healthcare. More than 1,500 surgeons, including many from the field of cardiac surgery, provided feedback for a new report on that very topic. 

READ MORE >
surgeon who uses AI
Share on Twitter Share on Facebook Share on Linkedin

Nearly half of all surgeons have considered leaving the profession due to burnout

Share on Twitter Share on Facebook Share on Linkedin
surgeon who uses AI
Burnout remains one of the biggest issues in modern healthcare. More than 1,500 surgeons, including many from the field of cardiac surgery, provided feedback for a new report on that very topic. 
READ MORE >

Featured Articles

Next-generation guide extension catheter delivers value during complex PCI

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 

READ MORE >
Angiography demonstrates a high-grade, modestly angulated stenosis (arrow) in the proximal segment of a large diagonal branch (A). Predilation performed with difficulty, and the GEC could not be advanced beyond stenosis even with “inch worming” techniques. (B). Advancement of the CrossFAST (C) beyond the proximal stent edge stenosis (a.), the position of the distal end of the outer catheter (b.), and the microcatheter tip (c.) are indicated. Photo courtesy of JSCAI
Share on Twitter Share on Facebook Share on Linkedin

Next-generation guide extension catheter delivers value during complex PCI

Share on Twitter Share on Facebook Share on Linkedin
Angiography demonstrates a high-grade, modestly angulated stenosis (arrow) in the proximal segment of a large diagonal branch (A). Predilation performed with difficulty, and the GEC could not be advanced beyond stenosis even with “inch worming” techniques. (B). Advancement of the CrossFAST (C) beyond the proximal stent edge stenosis (a.), the position of the distal end of the outer catheter (b.), and the microcatheter tip (c.) are indicated. Photo courtesy of JSCAI
The CrossFAST system was successfully used to deploy multiple stents after other devices fell short. 
READ MORE >

Moderate valve oversizing during TAVR boosts survival—too much may be less beneficial

Oversizing transcatheter heart valves can improve TAVR outcomes. There is still a reason to be cautious, however, especially when patients are receiving a balloon-expandable valve.

READ MORE >
Newsweek ranked the 50 best heart hospitals in the world
Share on Twitter Share on Facebook Share on Linkedin

Moderate valve oversizing during TAVR boosts survival—too much may be less beneficial

Share on Twitter Share on Facebook Share on Linkedin
Newsweek ranked the 50 best heart hospitals in the world
Oversizing transcatheter heart valves can improve TAVR outcomes. There is still a reason to be cautious, however, especially when patients are receiving a balloon-expandable valve.
READ MORE >

American College of Cardiology announces late-breaking clinical trials for ACC.26

The American College of Cardiology's 2026 annual meeting will include an all-time record of 60 late-breaking clinical studies.

READ MORE >
Semaglutide, the GLP-1 receptor agonist sold by Novo Nordisk under the brand names Wegovy and Ozempic, is associated with significant health benefits for patients with type 2 diabetes and peripheral artery disease (PAD), according to a late-breaking clinical trial presented at ACC.25, the annual meeting of the American College of Cardiology (ACC).
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology announces late-breaking clinical trials for ACC.26

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide, the GLP-1 receptor agonist sold by Novo Nordisk under the brand names Wegovy and Ozempic, is associated with significant health benefits for patients with type 2 diabetes and peripheral artery disease (PAD), according to a late-breaking clinical trial presented at ACC.25, the annual meeting of the American College of Cardiology (ACC).
The American College of Cardiology's 2026 annual meeting will include an all-time record of 60 late-breaking clinical studies.
READ MORE >

AATS wants to improve research in the field of cardiothoracic surgery

The American Association for Thoracic Surgery has announced a new partnership with the Cardiothoracic Surgical Trials Network. The groups plan on working together to address current challenges in cardiothoracic surgery research.

READ MORE >
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
Share on Twitter Share on Facebook Share on Linkedin

AATS wants to improve research in the field of cardiothoracic surgery

Share on Twitter Share on Facebook Share on Linkedin
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
The American Association for Thoracic Surgery has announced a new partnership with the Cardiothoracic Surgical Trials Network. The groups plan on working together to address current challenges in cardiothoracic surgery research.
READ MORE >

In Case You Missed It

TAVR linked to higher reintervention rate than SAVR in Evolut Low Risk trial update

The Evolut Low Risk trial has been one of cardiology’s most closely watched studies for years now. For the first five years after treatment, TAVR and SAVR were associated with comparable outcomes when treating low-risk patients. In this new six-year update, however, TAVR was linked to a heightened risk of reintervention not seen with SAVR. 

READ MORE >
Medtronic's Evolut Pro TAVR valve is designed to treat aortic stenosis.
Share on Twitter Share on Facebook Share on Linkedin

TAVR linked to higher reintervention rate than SAVR in Evolut Low Risk trial update

Share on Twitter Share on Facebook Share on Linkedin
Medtronic's Evolut Pro TAVR valve is designed to treat aortic stenosis.
The Evolut Low Risk trial has been one of cardiology’s most closely watched studies for years now. For the first five years after treatment, TAVR and SAVR were associated with comparable outcomes when treating low-risk patients. In this new six-year update, however, TAVR was linked to a heightened risk of reintervention not seen with SAVR. 
READ MORE >

Medtronic reports rising sales for cardiovascular devices—PFA tech leads the way

Medtronic's third quarter included a boom in PFA sales and a significant investment in Anteris Technologies. CEO Geoff Martha said the company hopes to make an even bigger impact in the structural heart space as time goes on.

READ MORE >
Among general cardiologists, for example, median compensation jumped nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps. Dollar money graphic showing increased finance.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic reports rising sales for cardiovascular devices—PFA tech leads the way

Share on Twitter Share on Facebook Share on Linkedin
Among general cardiologists, for example, median compensation jumped nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps. Dollar money graphic showing increased finance.
Medtronic's third quarter included a boom in PFA sales and a significant investment in Anteris Technologies. CEO Geoff Martha said the company hopes to make an even bigger impact in the structural heart space as time goes on.
READ MORE >

AI-powered MRI evaluations predict STEMI outcomes better than existing risk scores

Researchers found that their advanced machine learning model consistently outperformed current risk stratification techniques.

READ MORE >
Philips BlueSeal Horizon 3T MRI system shown at RSNA as a work in progress. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

AI-powered MRI evaluations predict STEMI outcomes better than existing risk scores

Share on Twitter Share on Facebook Share on Linkedin
Philips BlueSeal Horizon 3T MRI system shown at RSNA as a work in progress. Photo by Dave Fornell
Researchers found that their advanced machine learning model consistently outperformed current risk stratification techniques.
READ MORE >

In Other News

Court rules Leapfrog hospital safety grades ‘deceptive,’ orders removal of Tenet ratings

The nonprofit said it intends to appeal the U.S. District Court’s decision, though it will comply with the ruling for now. Five Tenet hospitals filed the lawsuit in April 2025, accusing Leapfrog of issuing ratings via a pay-to-play model.

READ MORE >
d-minus-school-letter-grade-600x400.jpg
Share on Twitter Share on Facebook Share on Linkedin

Court rules Leapfrog hospital safety grades ‘deceptive,’ orders removal of Tenet ratings

Share on Twitter Share on Facebook Share on Linkedin
d-minus-school-letter-grade-600x400.jpg
The nonprofit said it intends to appeal the U.S. District Court’s decision, though it will comply with the ruling for now. Five Tenet hospitals filed the lawsuit in April 2025, accusing Leapfrog of issuing ratings via a pay-to-play model.
READ MORE >

FDA clears next-gen image viewer from GE HealthCare that grants radiologists ‘anywhere access’

The regulatory decision applies to GEHC’s View, a key piece of the Chicago-based company’s Genesis Radiology Workspace. 

READ MORE >
cloud genesis stock gehc
Share on Twitter Share on Facebook Share on Linkedin

FDA clears next-gen image viewer from GE HealthCare that grants radiologists ‘anywhere access’

Share on Twitter Share on Facebook Share on Linkedin
cloud genesis stock gehc
The regulatory decision applies to GEHC’s View, a key piece of the Chicago-based company’s Genesis Radiology Workspace. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis
Shockwave Medical's new IVL catheter | BATMAN to the rescue | Antiplatelet drugs after PCI | FDA announces recalls
When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more
TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Current page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup